Deutsche Bank rates as Buy (1) - Danone and P&G have offered profit warnings but in Deutsche's view while this suggests some market softening there are also company specific issues coming into play.

As a result the broker retains its earnings estimates for or and makes no change in Buy rating.

- RESMED INC

UBS rates as Buy (1) - Target US$35.75. The broker notes Medicare in the US is looking at jiggling around some rules as to how breathing equipment can be replaced. With UBS expects some may be worried about this, as Medicare makes up about 20% of the market, the broker has no worries and expects it will be business as usual.

Buy call, target and forecasts are maintained.

- FAIRFAX MEDIA LIMITED

RBS Australia rates as Buy (1) - Target $1.10 (was $1.20). The broker has taken a close look at the company's metro mastheads post the the recent restructuring announcement and the introduction of online paywalls.

RBS comes away thinking that the combination of online revenue growth and the ongoing push for cost reductions will see the metro mastheads remain profitable even if print revenue continues to slide. Otherwise, the broker thinks the stock is cheap and expects it must re-rate at some point, but only after earnings stabilise, which wont happen until advertising conditions start to improve. Buy call maintained.

- RAMSAY HEALTH CARE LIMITED

Credit Suisse rates as Neutral (3) - While some may think public hospitals are shifting share at the expense of private operators, the broker doesn't think this this happening. Instead, CS says the number of private patients is simply increasing. Neutral call, target and forecasts are maintained.

- INSURANCE AUSTRALIA GROUP LIMITED

UBS rates as Neutral (3) - Target $3.50 (was $3.25). Despite the company saying so previously, the broker now admits natural perils costs may well not exceed allowance.

The view sees the broker lift its margin forecasts for the year, seeing a 5% increase to FY12 EPS forecasts. Neutral call maintained with a slightly higher target.

- TIGERS REALM COAL LIMITED

Credit Suisse rates as Outperform (1) - Target $0.35 (was $0.55). The broker notes the company has confirmed it will quit its Landazuri project in Colombia to focus on its larger Amaam project in Russia.

CS notes the move will help ease near term funding pressures and with a resource upgrade expected at Amaam, the Buy call is maintained.

- ILUKA RESOURCES LIMITED

RBS Australia rates as Upgrade to Buy from Hold (1) - RBS has updated its commodity price forecasts, which results in significant changes to forecasts for the mining sector. In the case of ka, the price target slips 38c to $15.78 and the recommendation is upgraded to Buy from Hold.

- GRANGE RESOURCES LIMITED

RBS Australia rates as Upgrade to Buy from Hold (1) - RBS has updated its commodity price forecasts, which results in significant changes to forecasts for the mining sector. In the case of Grange, the price target lifts 4c to 72c and the recommendation is upgraded to Buy from Hold.

Keep reading - next article

Bernanke testimony boosts European stocks

23/05/2013 05:19Sydney, Australia. 23 May,2013

Search RateCity

Find a personal loan

Find a credit card

Find a home loan

Find a savings account